Mallory bodies formed in proteasome-depleted hepatocytes: An immunohistochemical study

Fawzia Bardag-Gorce, Barbara Alan French, Yan He Lue, Victoria Nguyen, Yu-Jui Yvonne Wan, Samuel W. French

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Mallory bodies (MBs) are aggregates of proteins, principally cytokeratin proteins found in liver cells. They are also found in a few other cell types such as type II pneumocytes and trophoblasts. Studies on the liver thus far indicate that MBs are derived from hyperphosphorylated, heavily ubiquitinated proteins which have undergone conformational change. The aggregated protein may accumulate because of the failure of the proteasome to remove the altered proteins from the cytoplasm of liver cells. To investigate this possibility, the proteasomes were assessed immunohistochemically in individual liver cells of mice fed a drug which induced MB formation. To accelerate and enhance MB formation, cytochrome P450 2EI knockout mice were used. Proteasomes in individual cells were visualized by immunofluorescence using an antibody to a subunit of the proteasome (P25). The results showed that the groups of liver cells that had formed MBs were often partially depleted of proteasomes. These findings support the possibility that MBs formed as a result of the loss of the proteasome to remove misfolded cytokeratin proteins. Thus MBs may share their pathogenesis with other types of cellular inclusions seen where proteins aggregate in the cytoplasm due to mutation, misfolding, or loss of proteasomes.

Original languageEnglish (US)
Pages (from-to)7-18
Number of pages12
JournalExperimental and Molecular Pathology
Volume70
Issue number1
DOIs
StatePublished - 2001

Fingerprint

Mallory Bodies
Proteasome Endopeptidase Complex
Hepatocytes
Liver
Keratins
Cytoplasm
Proteins
Ubiquitinated Proteins
Alveolar Epithelial Cells
Inclusion Bodies
Trophoblasts
Knockout Mice
Cytochrome P-450 Enzyme System
Fluorescent Antibody Technique
Cells
Mutation
Antibodies

Keywords

  • Aggresome
  • Conformational change
  • CYP2E1
  • Digestion
  • Phosphorylation
  • Proteasome
  • Ubiquitination

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Molecular Biology
  • Pathology and Forensic Medicine

Cite this

Mallory bodies formed in proteasome-depleted hepatocytes : An immunohistochemical study. / Bardag-Gorce, Fawzia; French, Barbara Alan; Lue, Yan He; Nguyen, Victoria; Wan, Yu-Jui Yvonne; French, Samuel W.

In: Experimental and Molecular Pathology, Vol. 70, No. 1, 2001, p. 7-18.

Research output: Contribution to journalArticle

Bardag-Gorce, Fawzia ; French, Barbara Alan ; Lue, Yan He ; Nguyen, Victoria ; Wan, Yu-Jui Yvonne ; French, Samuel W. / Mallory bodies formed in proteasome-depleted hepatocytes : An immunohistochemical study. In: Experimental and Molecular Pathology. 2001 ; Vol. 70, No. 1. pp. 7-18.
@article{3ddeb393800a4612b02f2ec075624d3d,
title = "Mallory bodies formed in proteasome-depleted hepatocytes: An immunohistochemical study",
abstract = "Mallory bodies (MBs) are aggregates of proteins, principally cytokeratin proteins found in liver cells. They are also found in a few other cell types such as type II pneumocytes and trophoblasts. Studies on the liver thus far indicate that MBs are derived from hyperphosphorylated, heavily ubiquitinated proteins which have undergone conformational change. The aggregated protein may accumulate because of the failure of the proteasome to remove the altered proteins from the cytoplasm of liver cells. To investigate this possibility, the proteasomes were assessed immunohistochemically in individual liver cells of mice fed a drug which induced MB formation. To accelerate and enhance MB formation, cytochrome P450 2EI knockout mice were used. Proteasomes in individual cells were visualized by immunofluorescence using an antibody to a subunit of the proteasome (P25). The results showed that the groups of liver cells that had formed MBs were often partially depleted of proteasomes. These findings support the possibility that MBs formed as a result of the loss of the proteasome to remove misfolded cytokeratin proteins. Thus MBs may share their pathogenesis with other types of cellular inclusions seen where proteins aggregate in the cytoplasm due to mutation, misfolding, or loss of proteasomes.",
keywords = "Aggresome, Conformational change, CYP2E1, Digestion, Phosphorylation, Proteasome, Ubiquitination",
author = "Fawzia Bardag-Gorce and French, {Barbara Alan} and Lue, {Yan He} and Victoria Nguyen and Wan, {Yu-Jui Yvonne} and French, {Samuel W.}",
year = "2001",
doi = "10.1006/exmp.2000.2343",
language = "English (US)",
volume = "70",
pages = "7--18",
journal = "Experimental and Molecular Pathology",
issn = "0014-4800",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Mallory bodies formed in proteasome-depleted hepatocytes

T2 - An immunohistochemical study

AU - Bardag-Gorce, Fawzia

AU - French, Barbara Alan

AU - Lue, Yan He

AU - Nguyen, Victoria

AU - Wan, Yu-Jui Yvonne

AU - French, Samuel W.

PY - 2001

Y1 - 2001

N2 - Mallory bodies (MBs) are aggregates of proteins, principally cytokeratin proteins found in liver cells. They are also found in a few other cell types such as type II pneumocytes and trophoblasts. Studies on the liver thus far indicate that MBs are derived from hyperphosphorylated, heavily ubiquitinated proteins which have undergone conformational change. The aggregated protein may accumulate because of the failure of the proteasome to remove the altered proteins from the cytoplasm of liver cells. To investigate this possibility, the proteasomes were assessed immunohistochemically in individual liver cells of mice fed a drug which induced MB formation. To accelerate and enhance MB formation, cytochrome P450 2EI knockout mice were used. Proteasomes in individual cells were visualized by immunofluorescence using an antibody to a subunit of the proteasome (P25). The results showed that the groups of liver cells that had formed MBs were often partially depleted of proteasomes. These findings support the possibility that MBs formed as a result of the loss of the proteasome to remove misfolded cytokeratin proteins. Thus MBs may share their pathogenesis with other types of cellular inclusions seen where proteins aggregate in the cytoplasm due to mutation, misfolding, or loss of proteasomes.

AB - Mallory bodies (MBs) are aggregates of proteins, principally cytokeratin proteins found in liver cells. They are also found in a few other cell types such as type II pneumocytes and trophoblasts. Studies on the liver thus far indicate that MBs are derived from hyperphosphorylated, heavily ubiquitinated proteins which have undergone conformational change. The aggregated protein may accumulate because of the failure of the proteasome to remove the altered proteins from the cytoplasm of liver cells. To investigate this possibility, the proteasomes were assessed immunohistochemically in individual liver cells of mice fed a drug which induced MB formation. To accelerate and enhance MB formation, cytochrome P450 2EI knockout mice were used. Proteasomes in individual cells were visualized by immunofluorescence using an antibody to a subunit of the proteasome (P25). The results showed that the groups of liver cells that had formed MBs were often partially depleted of proteasomes. These findings support the possibility that MBs formed as a result of the loss of the proteasome to remove misfolded cytokeratin proteins. Thus MBs may share their pathogenesis with other types of cellular inclusions seen where proteins aggregate in the cytoplasm due to mutation, misfolding, or loss of proteasomes.

KW - Aggresome

KW - Conformational change

KW - CYP2E1

KW - Digestion

KW - Phosphorylation

KW - Proteasome

KW - Ubiquitination

UR - http://www.scopus.com/inward/record.url?scp=0035570009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035570009&partnerID=8YFLogxK

U2 - 10.1006/exmp.2000.2343

DO - 10.1006/exmp.2000.2343

M3 - Article

C2 - 11170786

AN - SCOPUS:0035570009

VL - 70

SP - 7

EP - 18

JO - Experimental and Molecular Pathology

JF - Experimental and Molecular Pathology

SN - 0014-4800

IS - 1

ER -